49 min
2024 Policy Preview: An Interview with Dr. Mark McClellan Prescription for Better Access
-
- Medicine
Scott and Mark welcome Dr. Mark McClellan, a distinguished health policy expert who has served as the Commissioner of the FDA and the Administrator of CMS, to look ahead at the major policy activities in 2024. They discuss how the government's role as regulator and purchaser of drugs will influence the drug industry and the patient's ability to access and afford medicines this year. They also discuss the challenges and opportunities for improving public health and the emerging role of artificial intelligence.
Dr. Mark McClellan, PhD, Director and Professor of Business, Medicine and Policy at the Duke-Margolis Center for Health Policy at Duke University
IRA
Medicare Part D
Pharmacy Benefit Managers (PBMs)
Medicare Advantage
FDA commissioner Rob Califf
The Ryan White HIV/AIDS Program (RWHAP) Part B
Medicare Modernization Act
FDA
FDA's Office of Regulatory Affairs
Centers for Medicare & Medicaid Services (CMS)
Centers for Disease Control and Prevention (CDC)
Per Member Per Month (PMPM) billing
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
Scott and Mark welcome Dr. Mark McClellan, a distinguished health policy expert who has served as the Commissioner of the FDA and the Administrator of CMS, to look ahead at the major policy activities in 2024. They discuss how the government's role as regulator and purchaser of drugs will influence the drug industry and the patient's ability to access and afford medicines this year. They also discuss the challenges and opportunities for improving public health and the emerging role of artificial intelligence.
Dr. Mark McClellan, PhD, Director and Professor of Business, Medicine and Policy at the Duke-Margolis Center for Health Policy at Duke University
IRA
Medicare Part D
Pharmacy Benefit Managers (PBMs)
Medicare Advantage
FDA commissioner Rob Califf
The Ryan White HIV/AIDS Program (RWHAP) Part B
Medicare Modernization Act
FDA
FDA's Office of Regulatory Affairs
Centers for Medicare & Medicaid Services (CMS)
Centers for Disease Control and Prevention (CDC)
Per Member Per Month (PMPM) billing
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
49 min